NCT06533020

Brief Summary

The purpose of the research study is to examine the long-term outcomes of complex and conversion total hip arthroplasty procedures. By means of both retrospective (chart review) and prospective (in-person clinic visits) radiographs and validated patient-reported outcome scores including the Hip Disability and Osteoarthritis Outcome Score (HOOS) and the Patient-Reported Outcomes Measurement Information System (PROMIS), the research team aims to collect, analyze, and summarize the outcome data. The outcomes of the follow-up appointment will be analyzed in comparison to previous findings over various intervals to assess changes over time, if data is available.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
210

participants targeted

Target at P75+ for all trials

Timeline
15mo left

Started Oct 2024

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress56%
Oct 2024Jul 2027

First Submitted

Initial submission to the registry

July 24, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 1, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

October 6, 2024

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2027

Last Updated

December 9, 2025

Status Verified

December 1, 2025

Enrollment Period

2.8 years

First QC Date

July 24, 2024

Last Update Submit

December 5, 2025

Conditions

Outcome Measures

Primary Outcomes (4)

  • PROMIS SF v1.1-Pain Interference 8a

    The Patient-Reported Outcomes Measurement Information System (PROMIS) SF v1.1-Pain Interference 8a measures the amount of pain interference in daily life. Possible scores range from "not at all" (1) to "very much" (5), with higher scores indicating a worse outcome (more pain interference).

    once during the 36-month total study duration, preferably during initial recruitment, but open to collection at any time during the study timeframe

  • PROMIS SF v2.0 - Physical Function 20a

    The Patient-Reported Outcomes Measurement Information System (PROMIS) SF v2.0 - Physical Function 20a measures the level of individual physical function in daily life. Possible scores range from "without any difficulty" (1) to "unable to do" (5) and "not at all" (1) to "cannot do" (5), with higher scores indicating a worse outcome (less physical function ability).

    once during the 36-month total study duration, preferably during initial recruitment, but open to collection at any time during the study timeframe

  • HOOS

    The Hip Disability and Osteoarthritis Outcome Score (HOOS) measures an individual's feelings about their hip and how well they are able to do usual activities, based on symptoms, stiffness, pain, daily living function, sports and recreational activities function, and quality of life. Possible scores range from "never" (1) to "always" (5) and "none" (1) to "extreme" (5), with higher scores indicating a worse outcome.

    once during the 36-month total study duration, preferably during initial recruitment, but open to collection at any time during the study timeframe

  • Radiographic Findings

    Standard radiographs of implanted hip to assess device efficacy and other potential anomalies. Collected during in-person clinic visits or from chart review if the patients have had hip radiographs at UNC in the past two years.

    once during the 36-month total study duration, preferably during screening for initial recruitment, but open to collection at any time during the study timeframe

Secondary Outcomes (2)

  • Number of participants with comorbidities

    Up to 36-months total study duration

  • Number of participants with complications

    Up to 36 months total study duration

Study Arms (2)

Complex Total Hip Arthroplasty

Participants who have undergone complex total hip arthroplasty within the last 10 years

Conversion Total Hip Arthroplasty

Participants who have undergone conversion total hip arthroplasty within the last 5 years

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

UNC Orthopaedics

You may qualify if:

  • Having undergone a conversion total hip arthroplasty (THA) more than five years ago or a complex THA more than ten years ago done by a UNC Health-affiliated physician
  • Willingness to receive follow-up care from a UNC Health-affiliated physician or provide outcome data regarding this surgical intervention
  • Able to speak and read English
  • Able to consent to participation

You may not qualify if:

  • Less than 18 years of age
  • Incarcerated status

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of North Carolina at Chapel Hill

Chapel Hill, North Carolina, 27599, United States

Location

Study Officials

  • Alecia Rajesh

    University of North Carolina, Chapel Hill

    PRINCIPAL INVESTIGATOR
  • Ishani Deliwala

    University of North Carolina, Chapel Hill

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 24, 2024

First Posted

August 1, 2024

Study Start

October 6, 2024

Primary Completion (Estimated)

July 31, 2027

Study Completion (Estimated)

July 31, 2027

Last Updated

December 9, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will share

Deidentified individual data that supports the results will be shared beginning 9 to 36 months following publication provided the investigator who proposes to use the data has approval from an Institutional Review Board (IRB), Independent Ethics Committee (IEC), or Research Ethics Board (REB), as applicable, and executes a data use/sharing agreement with UNC.

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
Beginning 9 and continuing 36 months following publication
Access Criteria
Investigator has approved IRB, IEC REB and an executed data use/sharing agreement with UNC.

Locations